A Phase I/II Study of Dose and Administration of Non-Glycosylated Bacterially Synthesized G-M CSF in Chemotherapy-Induced Neutropenia in Patients with Non-Hodgkin's Lymphomas-Reference-Cited by-同舟云学术

A Phase I/II Study of Dose and Administration of Non-Glycosylated Bacterially Synthesized G-M CSF in Chemotherapy-Induced Neutropenia in Patients with Non-Hodgkin's Lymphomas

Published:1992-01 Issue:3 Volume:7 Page:217-224
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hovgaard D.,Nissen N. I.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199209053626

Reference25 articles.

1. The Human Hematopoietic Colony-Stimulating Factors

2. Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.

3. Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins

4. Biologic properties in vitro of a recombinant human granulocyte- macrophage colony-stimulating factor

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel;Annals of Oncology;2010-12

2. Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX;European Journal of Cancer;2009-07

3. Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor;European Journal of Haematology;2009-04-24

4. Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.;European Journal of Haematology;2009-04-24

5. How to calculate the dose of chemotherapy;British Journal of Cancer;2002-04